JPMorgan Starts Immunome Inc. (IMNM) at Overweight, 'Morphing into a New R&D Powerhouse'
Tweet Send to a Friend
(Updated - April 30, 2024 4:45 AM EDT)
JPMorgan analyst Brian Cheng initiates coverage on Immunome Inc. (NASDAQ: IMNM) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Brian Cheng initiates coverage on Immunome Inc. (NASDAQ: IMNM) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
